[ Search ] [ Legislation ] [ Bill Summary ]
[ Home ] [ Back ] [ Bottom ]
| [ Introduced ] | [ Engrossed ] | [ Enrolled ] |
| [ House Amendment 001 ] |
90_HB0070sam002
LRB9000429RCksam05
1 AMENDMENT TO HOUSE BILL 70
2 AMENDMENT NO. . Amend House Bill 70 on page 1, lines
3 2 and 6 by changing "206," wherever it appears to "204,
4 208,"; and
5 by replacing lines 7 through 31 on page 1, all of pages 2, 3,
6 and 4, and lines 1 through 10 on page 5 with the following:
7 "(720 ILCS 570/204) (from Ch. 56 1/2, par. 1204)
8 Sec. 204. (a) The controlled substances listed in this
9 Section are included in Schedule I.
10 (b) Unless specifically excepted or unless listed in
11 another schedule, any of the following opiates, including
12 their isomers, esters, ethers, salts, and salts of isomers,
13 esters, and ethers, whenever the existence of such isomers,
14 esters, ethers and salts is possible within the specific
15 chemical designation:
16 (1) Acetylmethadol;
17 (1.1) Acetyl-alpha-methylfentanyl
18 (N-[1-(1-methyl-2-phenethyl)-
19 4-piperidinyl]-N-phenylacetamide);
20 (2) Allylprodine;
21 (3) Alphacetylmethadol, except
22 levo-alphacetylmethadol (also known as levo-alpha-
-2- LRB9000429RCksam05
1 acetylmethadol, levomethadyl acetate, or LAAM);
2 (4) Alphameprodine;
3 (5) Alphamethadol;
4 (6) Alpha-methylfentanyl
5 (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
6 propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-
7 propanilido) piperidine;
8 (6.1) Alpha-methylthiofentanyl
9 (N-[1-methyl-2-(2-thienyl)ethyl-
10 4-piperidinyl]-N-phenylpropanamide);
11 (7) 1-methyl-4-phenyl-4-proprionoxypiperidine
12 (MPPP);
13 (7.1) PEPAP
14 (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
15 (8) Benzethidine;
16 (9) Betacetylmethadol;
17 (9.1) Beta-hydroxyfentanyl
18 (N-[1-(2-hydroxy-2-phenethyl)-
19 4-piperidinyl]-N-phenylpropanamide);
20 (10) Betameprodine;
21 (11) Betamethadol;
22 (12) Betaprodine;
23 (13) Clonitazene;
24 (14) Dextromoramide;
25 (15) Diampromide;
26 (16) Diethylthiambutene;
27 (17) Difenoxin;
28 (18) Dimenoxadol;
29 (19) Dimepheptanol;
30 (20) Dimethylthiambutene;
31 (21) Dioxaphetylbutyrate;
32 (22) Dipipanone;
33 (23) Ethylmethylthiambutene;
34 (24) Etonitazene;
-3- LRB9000429RCksam05
1 (25) Etoxeridine;
2 (26) Furethidine;
3 (27) Hydroxpethidine;
4 (28) Ketobemidone;
5 (29) Levomoramide;
6 (30) Levophenacylmorphan;
7 (31) 3-Methylfentanyl
8 (N-[3-methyl-1-(2-phenylethyl)-
9 4-piperidyl]-N-phenylpropanamide);
10 (31.1) 3-Methylthiofentanyl
11 (N-[(3-methyl-1-(2-thienyl)ethyl-
12 4-piperidinyl]-N-phenylpropanamide);
13 (32) Morpheridine;
14 (33) Noracymethadol;
15 (34) Norlevorphanol;
16 (35) Normethadone;
17 (36) Norpipanone;
18 (36.1) Para-fluorofentanyl
19 (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
20 4-piperidinyl]propanamide);
21 (37) Phenadoxone;
22 (38) Phenampromide;
23 (39) Phenomorphan;
24 (40) Phenoperidine;
25 (41) Piritramide;
26 (42) Proheptazine;
27 (43) Properidine;
28 (44) Propiram;
29 (45) Racemoramide;
30 (45.1) Thiofentanyl
31 (N-phenyl-N-[1-(2-thienyl)ethyl-
32 4-piperidinyl]-propanamide);
33 (46) Tilidine;
34 (47) Trimeperidine;
-4- LRB9000429RCksam05
1 (48) Beta-hydroxy-3-methylfentanyl (other name:
2 N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
3 N-phenylpropanamide).
4 (c) Unless specifically excepted or unless listed in
5 another schedule, any of the following opium derivatives,
6 its salts, isomers and salts of isomers, whenever the
7 existence of such salts, isomers and salts of isomers is
8 possible within the specific chemical designation:
9 (1) Acetorphine;
10 (2) Acetyldihydrocodeine;
11 (3) Benzylmorphine;
12 (4) Codeine methylbromide;
13 (5) Codeine-N-Oxide;
14 (6) Cyprenorphine;
15 (7) Desomorphine;
16 (8) Diacetyldihydromorphine (Dihydroheroin);
17 (9) Dihydromorphine;
18 (10) Drotebanol;
19 (11) Etorphine (except hydrochloride salt);
20 (12) Heroin;
21 (13) Hydromorphinol;
22 (14) Methyldesorphine;
23 (15) Methyldihydromorphine;
24 (16) Morphine methylbromide;
25 (17) Morphine methylsulfonate;
26 (18) Morphine-N-Oxide;
27 (19) Myrophine;
28 (20) Nicocodeine;
29 (21) Nicomorphine;
30 (22) Normorphine;
31 (23) Pholcodine;
32 (24) Thebacon.
33 (d) Unless specifically excepted or unless listed in
34 another schedule, any material, compound, mixture, or
-5- LRB9000429RCksam05
1 preparation which contains any quantity of the following
2 hallucinogenic substances, or which contains any of its
3 salts, isomers and salts of isomers, whenever the existence
4 of such salts, isomers, and salts of isomers is possible
5 within the specific chemical designation (for the purposes of
6 this paragraph only, the term "isomer" includes the optical,
7 position and geometric isomers):
8 (1) 3,4-methylenedioxyamphetamine
9 (alpha-methyl,3,4-methylenedioxyphenethylamine,
10 methylenedioxyamphetamine, MDA);
11 (1.1) Alpha-ethyltryptamine
12 (some trade or other names: etryptamine;
13 MONASE; alpha-ethyl-1H-indole-3-ethanamine;
14 3-(2-aminobutyl)indole; a-ET; and AET);
15 (2) 3,4-methylenedioxymethamphetamine (MDMA);
16 (2.1) 3,4-methylenedioxy-N-ethylamphetamine
17 (also known as: N-ethyl-alpha-methyl-
18 3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
19 and MDEA);
20 (3) 3-methoxy-4,5-methylenedioxyamphetamine,
21 (MMDA);
22 (4) 3,4,5-trimethoxyamphetamine (TMA);
23 (5) 5-hydroxydimethyltryptamine (Bufotenine);
24 (6) Diethyltryptamine (DET);
25 (7) Dimethyltryptamine (DMT);
26 (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
27 (9) Ibogaine (some trade and other names:
28 7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
29 6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
30 indole; Tabernanthe iboga);
31 (10) Lysergic acid diethylamide;
32 (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
33 (12) Peyote (meaning all parts of the plant
34 presently classified botanically as Lophophora williemaii
-6- LRB9000429RCksam05
1 Lemaire, whether growing or not, the seeds thereof, any
2 extract from any part of that plant, and every compound,
3 manufacture, salts, derivative, mixture, or preparation
4 of that plant, its seeds or extracts);
5 (13) N-ethyl-3-piperidyl benzilate (JB 318);
6 (14) N-methyl-3-piperidyl benzilate;
7 (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
8 (also known as N-hydroxy-alpha-methyl-
9 3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
10 (15) Parahexyl; some trade or other names:
11 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
12 dibenzo (b,d) pyran; Synhexyl;
13 (16) Psilocybin;
14 (17) Psilocyn;
15 (18) Alpha-methyltryptamine (AMT);
16 (19) 2,5-dimethoxyamphetamine
17 (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
18 (20) 4-bromo-2,5-dimethoxyamphetamine
19 (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
20 4-bromo-2,5-DMA);
21 (21) 4-methoxyamphetamine
22 (4-methoxy-alpha-methylphenethylamine;
23 paramethoxyamphetamine; PMA);
24 (22) Thiophene analog of phencyclidine (TPCP);
25 (23) Ethylamine analog of phencyclidine. Some
26 trade or other names: N-ethyl-l-phenylcyclohexylamine,
27 (l-phenylcyclohexyl) ethylamine, N-(l-phenylcyclohexyl)
28 ethylamine, cyclohexamine, PCE;
29 (24) Pyrrolidine analog of phencyclidine. Some
30 trade or other names: l-(l-phenylcyclohexyl) pyrrolidine,
31 PCPy, PHP;
32 (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
33 (26) 2,5-dimethoxy-4-ethylamphetamine
34 (another name: DOET);
-7- LRB9000429RCksam05
1 (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
2 (another name: TCPy);
3 (28) 3,4-methylenedioxy amphetamine;
4 (29) Thiophene analog of phencyclidine (some trade
5 or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
6 2-thienyl analog of phencyclidine; TPCP; TCP);
7 (30) Bufotenine (some trade or other names:
8 3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
9 3-(2-dimethylaminoethyl)-5-indolol;
10 5-hydroxy-N,N-dimethyltryptamine;
11 N,N-dimethylserotonin; mappine).
12 (e) Unless specifically excepted or unless listed in
13 another schedule, any material, compound, mixture, or
14 preparation which contains any quantity of the following
15 substances having a depressant effect on the central nervous
16 system, including its salts, isomers, and salts of isomers
17 whenever the existence of such salts, isomers, and salts of
18 isomers is possible within the specific chemical designation:
19 (1) mecloqualone; and
20 (2) methaqualone; and .
21 (3) gamma hydroxybutyric acid.
22 (f) Unless specifically excepted or unless listed in
23 another schedule, any material, compound, mixture, or
24 preparation which contains any quantity of the following
25 substances having a stimulant effect on the central nervous
26 system, including its salts, isomers, and salts of isomers:
27 (1) Fenethylline;
28 (2) N-ethylamphetamine;
29 (3) Aminorex (some other names:
30 2-amino-5-phenyl-2-oxazoline; aminoxaphen;
31 4-5-dihydro-5-phenyl-2-oxazolamine) and its
32 salts, optical isomers, and salts of optical isomers;
33 (4) Methcathinone (some other names:
34 2-methylamino-1-phenylpropan-1-one;
-8- LRB9000429RCksam05
1 Ephedrone; 2-(methylamino)-propiophenone;
2 alpha-(methylamino)propiophenone; N-methylcathinone;
3 methycathinone; Monomethylpropion; UR 1431) and its
4 salts, optical isomers, and salts of optical isomers;
5 (5) Chathinone (some trade or other names:
6 2-aminopropiophenone; alpha-aminopropiophenone;
7 2-amino-1-phenyl-propanone; norephedrone);
8 (6) N,N-dimethylamphetamine (also known as:
9 N,N-alpha-trimethyl-benzeneethanamine;
10 N,N-alpha-trimethylphenethylamine);
11 (7) (+ or -) cis-4-methylaminorex ((+ or -) cis-
12 4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine).
13 (Source: P.A. 88-168; 89-202, eff. 10-1-95.)
14 (720 ILCS 570/208) (from Ch. 56 1/2, par. 1208)
15 Sec. 208. (a) The controlled substances listed in this
16 Section are included in Schedule III.
17 (b) Unless specifically excepted or unless listed in
18 another schedule, any material, compound, mixture, or
19 preparation which contains any quantity of the following
20 substances having a stimulant effect on the central nervous
21 system, including its salts, isomers (whether optical
22 position, or geometric), and salts of such isomers whenever
23 the existence of such salts, isomers, and salts of isomers is
24 possible within the specific chemical designation;
25 (1) Those compounds, mixtures, or preparations in
26 dosage unit form containing any stimulant substances
27 listed in Schedule II which compounds, mixtures, or
28 preparations were listed on August 25, 1971, as excepted
29 compounds under Title 21, Code of Federal Regulations,
30 Section 308.32, and any other drug of the quantitative
31 composition shown in that list for those drugs or which
32 is the same except that it contains a lesser quantity of
33 controlled substances;
-9- LRB9000429RCksam05
1 (2) Benzphetamine;
2 (3) Chlorphentermine;
3 (4) Clortermine;
4 (5) Phendimetrazine.
5 (c) Unless specifically excepted or unless listed in
6 another schedule, any material, compound, mixture, or
7 preparation which contains any quantity of the following
8 substances having a potential for abuse associated with a
9 depressant effect on the central nervous system:
10 (1) Any compound, mixture, or preparation
11 containing amobarbital, secobarbital, pentobarbital or
12 any salt thereof and one or more other active medicinal
13 ingredients which are not listed in any schedule;
14 (2) Any suppository dosage form containing
15 amobarbital, secobarbital, pentobarbital or any salt of
16 any of these drugs and approved by the Federal Food and
17 Drug Administration for marketing only as a suppository;
18 (3) Any substance which contains any quantity of a
19 derivative of barbituric acid, or any salt thereof:
20 (4) Chlorhexadol;
21 (5) Methyprylon;
22 (6) Sulfondiethylmethane;
23 (7) Sulfonethylmethane;
24 (8) Sulfonmethane;
25 (9) Lysergic acid;
26 (10) Lysergic acid amide;
27 (10.1) Tiletamine or zolazepam or both, or any salt
28 of either of them.
29 Some trade or other names for a tiletamine-zolazepam
30 combination product: Telazol.
31 Some trade or other names for Tiletamine:
32 2-(ethylamino)-2-(2-thienyl)-cyclohexanone.
33 Some trade or other names for zolazepam:
34 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-
-10- LRB9000429RCksam05
1 [3,4-e], [1,4]-diazepin-7(1H)-one, and flupyrazapon.
2 (11) Any material, compound, mixture or preparation
3 containing not more than 12.5 milligrams of pentazocine
4 or any of its salts, per 325 milligrams of aspirin;
5 (12) Any material, compound, mixture or preparation
6 containing not more than 12.5 milligrams of pentazocine
7 or any of its salts, per 325 milligrams of acetaminophen;
8 (13) Any material, compound, mixture or preparation
9 containing not more than 50 milligrams of pentazocine or
10 any of its salts plus naloxone HCl USP 0.5 milligrams,
11 per dosage unit; .
12 (14) Ketamine.
13 (d) Nalorphine.
14 (e) Unless specifically excepted or unless listed in
15 another schedule, any material, compound, mixture, or
16 preparation containing limited quantities of any of the
17 following narcotic drugs, or their salts calculated as the
18 free anhydrous base or alkaloid, as set forth below:
19 (1) not more than 1.8 grams of codeine per 100
20 milliliters or not more than 90 milligrams per dosage
21 unit, with an equal or greater quantity of an
22 isoquinoline alkaloid of opium;
23 (2) not more than 1.8 grams of codeine per 100
24 milliliters or not more than 90 milligrams per dosage
25 unit, with one or more active non-narcotic ingredients in
26 recognized therapeutic amounts;
27 (3) not more than 300 milligrams of
28 dihydrocodeinone per 100 milliliters or not more than 15
29 milligrams per dosage unit, with a fourfold or greater
30 quantity of an isoquinoline alkaloid of opium;
31 (4) not more than 300 milligrams of
32 dihydrocodeinone per 100 milliliters or not more than 15
33 milligrams per dosage unit, with one or more active,
34 non-narcotic ingredients in recognized therapeutic
-11- LRB9000429RCksam05
1 amounts;
2 (5) not more than 1.8 grams of dihydrocodeine per
3 100 milliliters or not more than 90 milligrams per dosage
4 unit, with one or more active, non-narcotic ingredients
5 in recognized therapeutic amounts;
6 (6) not more than 300 milligrams of ethylmorphine
7 per 100 milliliters or not more than 15 milligrams per
8 dosage unit, with one or more active, non-narcotic
9 ingredients in recognized therapeutic amounts;
10 (7) not more than 500 milligrams of opium per 100
11 milliliters or per 100 grams, or not more than 25
12 milligrams per dosage unit, with one or more active,
13 non-narcotic ingredients in recognized therapeutic
14 amounts;
15 (8) not more than 50 milligrams of morphine per 100
16 milliliters or per 100 grams with one or more active,
17 non-narcotic ingredients in recognized therapeutic
18 amounts.
19 (f) Anabolic steroids, except the following anabolic
20 steroids that are exempt:
21 (1) Androgyn L.A.;
22 (2) Andro-Estro 90-4;
23 (3) depANDROGYN;
24 (4) DEPO-T.E.;
25 (5) depTESTROGEN;
26 (6) Duomone;
27 (7) DURATESTRIN;
28 (8) DUO-SPAN II;
29 (9) Estratest;
30 (10) Estratest H.S.;
31 (11) PAN ESTRA TEST;
32 (12) Premarin with Methyltestosterone;
33 (13) TEST-ESTRO Cypionates;
34 (14) Testosterone Cyp 50 Estradiol Cyp 2;
-12- LRB9000429RCksam05
1 (15) Testosterone Cypionate-Estradiol Cypionate
2 injection; and
3 (16) Testosterone Enanthate-Estradiol Valerate
4 injection.
5 (g) The Department may except by rule any compound,
6 mixture, or preparation containing any stimulant or
7 depressant substance listed in subsection (b) from the
8 application of all or any part of this Act if the compound,
9 mixture, or preparation contains one or more active medicinal
10 ingredients not having a stimulant or depressant effect on
11 the central nervous system, and if the admixtures are
12 included therein in combinations, quantity, proportion, or
13 concentration that vitiate the potential for abuse of the
14 substances which have a stimulant or depressant effect on the
15 central nervous system.
16 (Source: P.A. 88-168; 89-202, eff. 10-1-95.)".